The safety of analgesics is monitored through pharmacovigilance programs, which collect and analyze data on adverse drug reactions. Regulatory agencies, such as the FDA and EMA, play a key role in ensuring the safety of analgesics by reviewing clinical trial data and post-marketing surveillance reports. Healthcare providers are also encouraged to report any adverse effects observed in patients.
